Extract

The purpose of the Multi-National Gilenya Pregnancy Exposure Registry in Multiple Sclerosis (MS) is to continuously monitor, evaluate, and assess for major and minor teratogenic effects in the offspring of women exposed to Gilenya before (up to 8 weeks before last menstrual period) and during pregnancy in routine clinical practice. The overall aim is to collect and evaluate data on maternal, fetal, and infant outcomes and compare it with reference populations.

Inclusion criteria

• Multiple sclerosis

Country

• Australia
• Austria
• Belgium
• Canada
• Czech Republic
• Denmark
• Germany
• Norway
• Switzerland
• United Kingdom
• United States

Links

• ictrp
• nct